Anne Whitaker

Anne Whitaker is an Operating Partner at NewVale Capital.

Anne is a senior biopharmaceutical executive with extensive leadership experience across global commercial and development organizations. She has held executive roles at Bausch Health, Sanofi, and GlaxoSmithKline, and has served as Chief Executive Officer of multiple private and public development-stage companies. Anne currently serves on several industry boards, including ICON, Trinity Life Sciences, Bespak, QurAlis, Nykode Therapeutics, and Bryn Pharma.

Anne holds a BA in Chemistry from the University of North Alabama.